DHA Enterprise-Wide Commercial Solutions Opening (CSO)

The Defense Health Agency (DHA) has opened a Commercial Solutions Opening (CSO) that runs from 7 August 2026 through 6 August 2027. This CSO seeks commercial, off‑the‑shelf or readily modifiable products, services, and non‑developmental items that support DHA’s mission in medical digital solutions, medical services, and medical products. The Government will issue individual Areas of Interest (AoIs) throughout the window; each AoI will include a problem statement, evaluation criteria, submission instructions, and a due date. Awards may be made under FAR‑based firm‑fixed‑price contracts or Other Transaction Agreements (OTAs) for research, prototype, or experimental work. No budget ceilings are disclosed; pricing will be evaluated for reasonableness. Interested vendors should monitor DHA releases and be prepared to submit a pitched white‑paper, optional demonstration, and a full commercial proposal if invited. • Scope: Commercial health‑care IT, analytics, logistics, surveillance, medical‑product delivery, and related services. • Contract mechanisms: FAR‑based contracts (FFP or FFP‑with‑incentives) and OTAs (research, prototype, experimental). • Process: Phase I (pitch/white‑paper) → Phase II (optional oral demo) → Phase III (full proposal). • Timeline: Open window 07 Aug 2026 – 06 Aug 2027; AoI‑specific deadlines to be posted later.